H1N1 influenza is here

H1N1 influenza is here.

On 11 June WHO announced that the spread of H1N1 had reached pandemic phase 6. Since then countries around the world have increased their planning and preparedness for the continuing pandemic. Guidelines have been issued and circulated but confusion continues over their interpretation. We need to remind ourselves of the principles behind control measures and educate and reinforce standard infec...

2009 H1N1 Influenza Virus Seroepidemiology

Construction of Influenza A/H1N1 Virosomal Nanobioparticles

Background and Aims: Influenza is one of the main respiratory infections of humans, responsible for 300,000–500,000 annual deaths world-wide. Vaccination is one of the best ways to prevent infections including influenza. Influenza virosomes are virus-like particles, which retain the cell binding and membrane fusion properties of the native virus, but lack the ribonucleoprotein (RNP). A vi...

Swine influenza H1N1. Is your laboratory prepared?

Address correspondence and reprint request to: Dr. Sameera Aljohani, Department of Pathology and Laboratory Medicine, KAMC, Riyadh, Kingdom of Saudi Arabia. Tel. +966 (1) 2520088 Ext. 12817. Fax. +966 (1) 2520130. E-mail: [email protected] I A virus is a member of the family Orthomyxoviridae. Influenza viruses are enveloped, with a segmented, single-stranded RNA genome. This family also conta...

Design, Production, and Evaluation of Virosomes from H1N1 Influenza Virus

Background: The last two decades witnessed the spread of the first generation of influenza viruses. Influenza virosomes are promising tools in vaccine and immunotherapy programs because of their applications in various medical fields. The aim of the present study was to construct cationic virosomes derived from influenza virus using dialyzable detergent (DCPC) and cationic lipid (DOTAP) in vit...